152 related articles for article (PubMed ID: 21697410)
1. Identification of the primary tumour with the help of diffusion-weighted MRI in a patient with autosomal dominant polycystic kidney disease and metastatic renal cell carcinoma.
Zeile M; Andreou D; Poellinger A; Tunn PU; Dudeck O
Br J Radiol; 2011 Jul; 84(1003):e142-5. PubMed ID: 21697410
[TBL] [Abstract][Full Text] [Related]
2. Malignant renal neoplasms: correlation between ADC values and cellularity in diffusion weighted magnetic resonance imaging at 3 T.
Manenti G; Di Roma M; Mancino S; Bartolucci DA; Palmieri G; Mastrangeli R; Miano R; Squillaci E; Simonetti G
Radiol Med; 2008 Mar; 113(2):199-213. PubMed ID: 18386122
[TBL] [Abstract][Full Text] [Related]
3. Differential diagnosis of the small renal masses: role of the apparent diffusion coefficient of the diffusion-weighted MRI.
Mytsyk Y; Dutka I; Yuriy B; Maksymovych I; Caprnda M; Gazdikova K; Rodrigo L; Kruzliak P; Illjuk P; Farooqi AA
Int Urol Nephrol; 2018 Feb; 50(2):197-204. PubMed ID: 29230706
[TBL] [Abstract][Full Text] [Related]
4. Subtype differentiation of renal cell carcinoma using diffusion-weighted and blood oxygenation level-dependent MRI.
Choi YA; Kim CK; Park SY; Cho SW; Park BK
AJR Am J Roentgenol; 2014 Jul; 203(1):W78-84. PubMed ID: 24951231
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of the apparent diffusion coefficient value of metastatic bone tumours on diffusion-weighted MRI images: differences according to the types of primary tumour, the affected bones, and clinical factors.
Cha MJ; Yoon YC
Clin Radiol; 2015 Oct; 70(10):1116-21. PubMed ID: 26145186
[TBL] [Abstract][Full Text] [Related]
6. Autosomal dominant polycystic kidney disease: MR imaging evaluation using current techniques.
Mosetti MA; Leonardou P; Motohara T; Kanematsu M; Armao D; Semelka RC
J Magn Reson Imaging; 2003 Aug; 18(2):210-5. PubMed ID: 12884334
[TBL] [Abstract][Full Text] [Related]
7. The role of the ADC value in the characterisation of renal carcinoma by diffusion-weighted MRI.
Paudyal B; Paudyal P; Tsushima Y; Oriuchi N; Amanuma M; Miyazaki M; Taketomi-Takahashi A; Nakazato Y; Endo K
Br J Radiol; 2010 Apr; 83(988):336-43. PubMed ID: 19620174
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted MR imaging in the evaluation of renal tumours.
Squillaci E; Manenti G; Di Stefano F; Miano R; Strigari L; Simonetti G
J Exp Clin Cancer Res; 2004 Mar; 23(1):39-45. PubMed ID: 15149149
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype.
Goyal A; Sharma R; Bhalla AS; Gamanagatti S; Seth A; Iyer VK; Das P
Acta Radiol; 2012 Apr; 53(3):349-58. PubMed ID: 22496427
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of malignant and benign renal lesions using diffusion-weighted MRI with multiple b values.
Erbay G; Koc Z; Karadeli E; Kuzgunbay B; Goren MR; Bal N
Acta Radiol; 2012 Apr; 53(3):359-65. PubMed ID: 22334870
[TBL] [Abstract][Full Text] [Related]
11. Polycystic kidneys: a cautionary story.
Currie RJ; Freeman SJ; McCormick F; McGonigle RJ
Br J Radiol; 2007 Dec; 80(960):e305-9. PubMed ID: 18065639
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of diffusion-weighted imaging in the evaluation of renal masses.
Sandrasegaran K; Sundaram CP; Ramaswamy R; Akisik FM; Rydberg MP; Lin C; Aisen AM
AJR Am J Roentgenol; 2010 Feb; 194(2):438-45. PubMed ID: 20093607
[TBL] [Abstract][Full Text] [Related]
13. Characteristic MRI findings of sarcomatoid renal cell carcinoma dedifferentiated from clear cell renal carcinoma: radiological-pathological correlation.
Takeuchi M; Urano M; Hara M; Fujiyoshi Y; Inagaki H; Shibamoto Y
Clin Imaging; 2013; 37(5):908-12. PubMed ID: 23834905
[TBL] [Abstract][Full Text] [Related]
14. Systemic treatment of the metastatic renal cell carcinoma: usefulness of the apparent diffusion coefficient of diffusion-weighted MRI in prediction of early therapeutic response.
Mytsyk Y; Pasichnyk S; Dutka I; Dats I; Vorobets D; Skrzypczyk M; Uteuliyev Y; Botikova A; Gazdikova K; Kubatka P; Urdzik P; Kruzliak P
Clin Exp Med; 2020 May; 20(2):277-287. PubMed ID: 32026157
[TBL] [Abstract][Full Text] [Related]
15. Sarcomatoid renal cell carcinoma with autosomal dominant polycystic kidney disease: a case report and literature review.
Hakozaki Y; Uchiyama K; Yanai A; Yamada D; Kamijo Y; Ishibashi Y
CEN Case Rep; 2021 May; 10(2):199-207. PubMed ID: 33064294
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Utility of Diffusion-weighted Magnetic Resonance Imaging in Differentiating Small Solid Renal Tumors (≤ 4 cm) at 3.0T Magnetic Resonance Imaging.
Zhang HM; Wu YH; Gan Q; Lyu X; Zhu XL; Kuang M; Liu RB; Huang ZX; Yuan F; Liu XJ; Song B
Chin Med J (Engl); 2015 Jun; 128(11):1444-9. PubMed ID: 26021498
[TBL] [Abstract][Full Text] [Related]
17. Diffusion-weighted MRI in the evaluation of renal lesions: preliminary results.
Cova M; Squillaci E; Stacul F; Manenti G; Gava S; Simonetti G; Pozzi-Mucelli R
Br J Radiol; 2004 Oct; 77(922):851-7. PubMed ID: 15482997
[TBL] [Abstract][Full Text] [Related]
18. Diffusion-weighted MRI in inflammatory renal lesions: all that glitters is not RCC!
Goyal A; Sharma R; Bhalla AS; Gamanagatti S; Seth A
Eur Radiol; 2013 Jan; 23(1):272-9. PubMed ID: 22797980
[TBL] [Abstract][Full Text] [Related]
19. Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T.
Wang H; Cheng L; Zhang X; Wang D; Guo A; Gao Y; Ye H
Radiology; 2010 Oct; 257(1):135-43. PubMed ID: 20713607
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted MRI of renal cell carcinoma, upper tract urothelial carcinoma, and renal infection: a pictorial review.
Cogley JR; Nguyen DD; Ghobrial PM; Rakita D
Jpn J Radiol; 2013 Oct; 31(10):643-52. PubMed ID: 23999888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
